Neelesh Sharma, MD PhD

Vivace Therapeutics
Livingston, New Jersey, United States

Presentation(s):

• Paper 33 - SAFETY AND EARLY EFFICACY OF VT3989, A TEAD INHIBITOR, IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA (EHE): A PHASE I/II STUDY

  Friday, November 14, 2025
  10:30 AM - 12:00 PM EST

  Disclosure information not submitted.